logo
Select company
Select metric
-10%Return on Assets
VS
Market
30
Sector
70
Industry
87
History
85
$ 9.01Close
$ 8.77 - $ 25.14 52-Week Range
Ticker Information

Ticker

RNAC

Company Name

CARTESIAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARTESIAN THERAPEUTICS INC - Return on Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNAC - ROA Historical data
DateTotal AssetsNet Income Common StockReturn on Assets
6/30/2025$ 388.89M$ -38.89M-10%
3/31/2025$ 409.13M$ -42.52M-10.39%
12/31/2024$ 435.02M$ -77.42M-17.8%
9/30/2024$ 455.32M$ -249.04M-54.7%
6/30/2024$ 347.74M$ -233.86M-67.25%
3/31/2024$ 325.21M$ -254.87M-78.37%
12/31/2023$ 305.05M$ -219.71M-72.02%
9/30/2023$ 106.03M$ -36.16M-34.1%
6/30/2023$ 139.51M$ -35.05M-25.12%
3/31/2023$ 155.69M$ -15.06M-9.67%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) ROA stands at -37.75%.
  • Over the past 5 years, CARTESIAN THERAPEUTICS INC's average ROA has been -24.65%.
  • The median ROA for CARTESIAN THERAPEUTICS INC during this period was -25.08%
  • CARTESIAN THERAPEUTICS INC reached its highest ROA over the past 5 years at 23.41%.
  • The lowest ROA recorded by CARTESIAN THERAPEUTICS INC in the same timeframe -78.37%

CARTESIAN THERAPEUTICS INC's ROA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROA Benchmarks
CompanyROA
HUMA : HUMACYTE INC -42.26%NWBO : NORTHWEST BIOTHERAPEUTICS INC -282.76%MREO : MEREO BIOPHARMA GROUP PLC -79.11%INBX : INHIBRX BIOSCIENCES INC -77.17%CRDF : CARDIFF ONCOLOGY INC -67.39%BTAI : BIOXCEL THERAPEUTICS INC -197.56%CATX : PERSPECTIVE THERAPEUTICS INC -30.56%ADVM : ADVERUM BIOTECHNOLOGIES INC -191.18%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -659.56%LSTA : LISATA THERAPEUTICS INC -75.21%

Definition of Return on Assets

[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
Net Inc. Cmn. / Assets
(=) ROA
ROA for CARTESIAN THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -68.32M ] / Assets [ $ 181M ]
(=) ROA [ -37.75% ]

RNAC - Return on Assets, Last 5 years

-78.37%

Minimum

Mar 31, 2024

23.41%

Maximum

Sep 30, 2022

-24.65%

Average

-25.08%

Median

ROA Benchmark Analysis

The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.1% with a standard deviation of 10.63%.
The following table provides additional summary stats:
ROA in the Market:
filtered constituents3.45K
min-33.42%
max33.98%
average0.1%
median1.53%
std10.63%